On July 1, 2021, Kowa industries announced that it would do clinical trials for Ivermectin to treat COVID-19. As Pharma Japan reported, “Kowa directly received a request from Nobel laureate Satoshi Omura about conducting such a trial. Dr. Omura won the 2015 Nobel Prize in physiology or medicine for developing Ivermectin. Kowa is conducting the clinical…
Japanese company announces Ivermectin has antiviral properties
Posted on